SUN11602, with the CAS number 704869-38-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. The compound is typically evaluated for its pharmacokinetic properties, such as solubility, stability, and bioavailability, which are crucial for its effectiveness as a drug candidate. Additionally, SUN11602 may exhibit specific interactions with biological targets, making it a subject of interest in drug discovery and development. Its safety profile, including toxicity and side effects, is also a critical aspect of its characterization. Overall, SUN11602 represents a promising entity in the ongoing research aimed at developing new therapeutic agents. Further studies are essential to fully understand its mechanisms of action and potential applications in treating various diseases.

SUN11602

Find at CymitQuimica all products linked to CAS 704869-38-5. Enter now to get more information

SUN11602, an aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.

SUN 11602 is a 5-HT1A receptor agonist that has been shown to be neuroprotective in cell cultures and to have anti-cancer properties. SUN 11602 also protects against neuronal death, glutamate-induced excitotoxicity, and muscle diseases. The drug has been shown to increase the production of fatty acids and growth factors, which are important for cell proliferation. In addition, SUN 11602 has been shown to be a molecule with an effective dose of 10 µM.

CAS 704869-38-5: SUN11602

SUN11602

Ref: TM-T3714

SUN11602

Ref: 54-BUP10627

SUN11602

Ref: IN-DA00FGLJ

SUN 11602

Ref: 3D-EDB86938